A Double Blind, Randomized Study to Compare Influence of Niacin/Laropiprant on Functional and Morphological Characteristics of Arterial Wall and Parameters of Inflammation in Subjects With Coronary Heart Disease Already Treated With a Statin.

Trial Profile

A Double Blind, Randomized Study to Compare Influence of Niacin/Laropiprant on Functional and Morphological Characteristics of Arterial Wall and Parameters of Inflammation in Subjects With Coronary Heart Disease Already Treated With a Statin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 May 2014

At a glance

  • Drugs Niacin/laropiprant (Primary)
  • Indications Coronary disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Nov 2011 Actual initiation date (21 Apr 2010) added as reported by European Clinical Trials Database record.
    • 05 Oct 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
    • 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top